Senior insider sale
General Counsel at MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$337.0K
664.00 shares
What this filing means
KELLEY SHANNON T plans to sell 664.00 shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $337.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/20/2026ACC: 0001628280-26-058254
Officer· General Counsel
Since Mar 2026
664.00
Shares to sell
$337.0K
Approx. market value
664.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Grant
Vesting of Restricted Stock Units
8/15/2026
664.00Total acquired664.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/15/2026 | Restricted Stock Unit Grant Vesting of Restricted Stock Units | 664.00 | — |
| Total | 664.00 | ||
Planned & Completed Dispositions1
Nasdaq Stock MarketPlanned
Units to sell
664.00
Market value
$337.0K
8/17/2026
Total
Units
664.00
Value
$337.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/17/2026 | 664.00 | $337.0K | Nasdaq Stock Market | Planned |
| Total | 664.00 | $337.0K | ||